Lifestyle Intervention to Treat Diabetes in the Marshall Islands
Lifestyle Intervention Trial to Treat Type 2 Diabetes in the Republic of the Marshall Islands
1 other identifier
interventional
138
0 countries
N/A
Brief Summary
The Republic of the Marshall Islands has the highest prevalence of type 2 diabetes (T2D) in the world. This clinical trial tested whether a community-based, intensive, plant-rich lifestyle intervention with exercise is more effective for treating and managing T2D in the Republic of the Marshall Islands than the standard of diabetes care. The intensive lifestyle intervention consisted of a plant-rich diet and moderate exercise. It centered around a 12-week program of counseling and instruction on healthy eating, exercise, and stress management, as well as hands-on cooking classes and prepared meals. Cardiometabolic outcomes were assessed throughout the intervention and at 24 weeks. The present study is the first randomized clinical trial ever conducted in the Republic of the Marshall Islands and the first lifestyle intervention trial conducted in Micronesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes-mellitus
Started Jun 2006
Typical duration for not_applicable type-2-diabetes-mellitus
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2008
CompletedFirst Submitted
Initial submission to the registry
March 3, 2019
CompletedFirst Posted
Study publicly available on registry
March 5, 2019
CompletedMay 16, 2023
May 1, 2023
2.2 years
March 3, 2019
May 15, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
Fasting glucose
mg/dl
Change from Week 0 to Week 24
HbA1c
Percent
Change from Week 0 to Week 24
Fasting insulin
mU/l
Change from Week 0 to Week 24
HOMA-IR
Insulin resistance as measured by HOMA-IR
Change from Week 0 to Week 24
Usage of diabetes medications
Number as measured by the medication effect score
Change from Week 0 to Week 24
Secondary Outcomes (7)
Cholesterol (total, HDL, LDL) and triglycerides
Change from Week 0 to Week 24
Blood pressure
Change from Week 0 to Week 24
Heart rate
Change from Week 0 to Week 24
High-sensitivity C-reactive protein
Change from Week 0 to Week 24
Body weight
Change from Week 0 to Week 24
- +2 more secondary outcomes
Study Arms (2)
Standard of Diabetes Care
ACTIVE COMPARATORStandard of diabetes care in the Marshall Islands
Lifestyle Intervention
EXPERIMENTALPlant-based, whole foods diet with moderate exercise
Interventions
The standard of diabetes care consisted of standard treatment protocols used by the MOH Diabetes Clinic. These included placing T2D patients on anti-hyperglycemic agents appropriate to their HbA1c levels (including sulfonylureas, metformin, and insulin) and providing oral and written information about the importance of maintaining a healthy weight, eating a healthy diet, and getting regular exercise. Participants in the control group were instructed not to make changes in their diet and activity levels during the study.
The lifestyle intervention consisted of a high-fiber, low-fat, mostly plant-based diet and 30-60 minutes per day of culturally-relevant, moderate intensity exercise. Participants initially received 12 weeks of group educational classes and some prepared meals and then followed the lifestyle intervention on their own for the remaining 12 weeks. Group classes included informative sessions on healthy eating, exercise (both aerobic and strength training), and stress management, as well as hands-on cooking classes. Classes were delivered as a combination of PowerPoint presentations, practical workshops, dine-outs, shopping tours, and cooking classes with spouses.
Eligibility Criteria
You may qualify if:
- Resident of the Republic of Marshall Islands
- Aged 18 - 75 years
- HbA1c ≥ 8.0% or diagnosed with T2D and taking diabetes medication
- Medical clearance to participate from Diabetes Wellness Center (DWC) physicians.
You may not qualify if:
- Recent (≤3 months) change in a diabetes-related medication dosage
- A physical or medical condition that would impede participation in the lifestyle intervention (e.g., wheel-chair bound, unstable angina)
- Evidence of significant coronary heart disease
- Previous participation in an intensive lifestyle intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- United States Department of Defensecollaborator
- Loma Linda Universitycollaborator
- Brenda Davis Nutrition Consultation Servicescollaborator
- Canvasback Missions, Inc.collaborator
Related Publications (2)
Hanick CJ, Peterson CM, Davis BC, Sabate J, Kelly JH Jr. A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia. 2025 Feb;68(2):308-319. doi: 10.1007/s00125-024-06272-8. Epub 2024 Sep 21.
PMID: 39305340DERIVEDDavis BC, Jamshed H, Peterson CM, Sabate J, Harris RD, Koratkar R, Spence JW, Kelly JH Jr. An Intensive Lifestyle Intervention to Treat Type 2 Diabetes in the Republic of the Marshall Islands: Protocol for a Randomized Controlled Trial. Front Nutr. 2019 Jun 5;6:79. doi: 10.3389/fnut.2019.00079. eCollection 2019.
PMID: 31231656DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John H Kelly, M.D.
Loma Linda University; Black Hills Lifestyle Medicine Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 3, 2019
First Posted
March 5, 2019
Study Start
June 1, 2006
Primary Completion
July 31, 2008
Study Completion
July 31, 2008
Last Updated
May 16, 2023
Record last verified: 2023-05